BRASILIA, Dec 30 (Reuters) - Brazil's Fiocruz biomedical
institute will apply for emergency use authorization for
AstraZeneca's COVID-19 vaccine, the country's health
regulator Anvisa said on Wednesday.
In a statement on the Health Ministry's website, Anvisa said
it will take up to 10 days to review the emergency use request
once it is filed by Fiocruz, which is overseen by the federal
government. Earlier on Wednesday, AstraZeneca said it is working
to offer its COVID-19 vaccine to Brazilians as soon as possible.
(Reporting by Ricardo Brito and Jamie McGeever)